News 29.01.2026 Schlieren, Zurich – DiNAMIQS has appointed Kathrin Schneider as its new Head of Business Development for Europe and the Asia-Pacific region (APAC). According to the Schlieren-based life sciences company, she has experience in establishing structures that enable sustainable, long-term growth. DiNAMIQS, based in the Bio-Technopark Schlieren-Zurich, has expanded its management team...
Events, External events
Event date: 04.05.2026
The power of international collaboration
Since 2021, the Swiss Biotech Day has seen remarkable growth every year and has become a premier global biotechnology conference for life sciences professionals, fostering international collaboration and impactful partnerships. In 2025 it attracted more than 3,000 participants from 49 countries, including 25 international delegations. It...
News 19.01.2026 We are pleased to announce that our acquisition of Doppl SA, including the Sun Bioscience technology, has officially been completed. This milestone expands our capabilities in human-relevant 3D biology and strengthens the support we offer across preclinical research. Doppl brings a distinctive organoid technology portfolio featuring tessellated organoid arrays, a leading biobank,...
News 15.01.2026 Unlike typical award programs, this recognition is based entirely on platform performance metrics, reflecting real activity and real outcomes across global R&D teams. Over the past year, scientists requested and completed studies spanning: 🔹 in vitro toxicology 🔹 pharmacology and assay development 🔹 cell culture and characterization All delivered through an on-demand procurement workflow. Performance indicators...
News 14.01.2026 Zurich, Switzerland - 13.01.2026 Neurimmune today announced that the company joined the ACCESS-AD consortium, a new European initiative to accelerate the implementation of scientific innovations for Alzheimer’s disease (AD) management in real-world health systems. The international consortium - bringing together academic institutions, industry partners, SMEs and patient organisations - is a five-year...